Preliminary Q2 2024 Acquired IPRD and Licensing Income Schedule

Bristol-Myers Squibb Company published this content on July 03, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 24, 2025 at 21:48 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]